Phase I Study Of Crispr-Engineered Car-T Cells With Pd-1 Inactivation In Treating Mesothelin-Positive Solid Tumors.Zhenguang Wang,Meixia Chen,Yan Zhang,Yang Liu,Qingming Yang,Jing Nie,Lianjun Shen,Pengfei Jiang,Jiaping He,Xun Ye,Wei Cao,Haoyi Wang,Weidong HanJOURNAL OF CLINICAL ONCOLOGY(2020)引用 6|浏览27暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要